Primus‐E. Mullis

494 total citations
29 papers, 281 citations indexed

About

Primus‐E. Mullis is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Primus‐E. Mullis has authored 29 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Primus‐E. Mullis's work include Growth Hormone and Insulin-like Growth Factors (10 papers), Genetic Syndromes and Imprinting (4 papers) and Diabetes Management and Research (4 papers). Primus‐E. Mullis is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (10 papers), Genetic Syndromes and Imprinting (4 papers) and Diabetes Management and Research (4 papers). Primus‐E. Mullis collaborates with scholars based in Switzerland, United Kingdom and Italy. Primus‐E. Mullis's co-authors include Vibor Petkovic, Christa E. Flück, Andrée Eblé, K Zuppinger, Marco Janner, Matthias Kamber, Roland A. Ammann, Peter Diem, M G Bianchetti and Anita C. Truttmann and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Primus‐E. Mullis

29 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Primus‐E. Mullis Switzerland 10 131 91 70 52 39 29 281
Bogda Skowrońska Poland 12 97 0.7× 100 1.1× 93 1.3× 79 1.5× 27 0.7× 35 405
M. C. Carranza Spain 8 99 0.8× 68 0.7× 58 0.8× 54 1.0× 27 0.7× 12 407
Christine Cavalcanti-Proença United Kingdom 4 92 0.7× 146 1.6× 105 1.5× 60 1.2× 29 0.7× 4 313
Teresa Frazer United States 8 152 1.2× 82 0.9× 98 1.4× 43 0.8× 49 1.3× 8 371
Yiyang Zhan China 12 89 0.7× 40 0.4× 56 0.8× 40 0.8× 22 0.6× 23 309
Stefania Moia Italy 8 158 1.2× 40 0.4× 36 0.5× 23 0.4× 35 0.9× 14 297
Joseph M. Tibaldi United States 14 393 3.0× 82 0.9× 101 1.4× 127 2.4× 35 0.9× 26 524
Ross M. Fraser United Kingdom 12 98 0.7× 79 0.9× 183 2.6× 18 0.3× 26 0.7× 25 416
Andressa G. Amaral Brazil 10 67 0.5× 65 0.7× 95 1.4× 78 1.5× 65 1.7× 22 333
Witold Bauer Poland 12 69 0.5× 74 0.8× 118 1.7× 58 1.1× 38 1.0× 26 356

Countries citing papers authored by Primus‐E. Mullis

Since Specialization
Citations

This map shows the geographic impact of Primus‐E. Mullis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Primus‐E. Mullis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Primus‐E. Mullis more than expected).

Fields of papers citing papers by Primus‐E. Mullis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Primus‐E. Mullis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Primus‐E. Mullis. The network helps show where Primus‐E. Mullis may publish in the future.

Co-authorship network of co-authors of Primus‐E. Mullis

This figure shows the co-authorship network connecting the top 25 collaborators of Primus‐E. Mullis. A scholar is included among the top collaborators of Primus‐E. Mullis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Primus‐E. Mullis. Primus‐E. Mullis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flück, Christa E., et al.. (2016). Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type II. Biochemical Pharmacology. 124. 1–9. 4 indexed citations
2.
Petkovic, Vibor, et al.. (2016). Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing. Endocrinology. 157(10). 3972–3982. 6 indexed citations
3.
Eblé, Andrée, Marco Janner, Shaheena Parween, et al.. (2015). IGHD II: A NovelGH-1Gene Mutation (GH-L76P) Severely Affects GH Folding, Stability, and Secretion. The Journal of Clinical Endocrinology & Metabolism. 100(12). E1575–E1583. 5 indexed citations
4.
Schepper, Jean De, Johan Vanderfaeillie, Primus‐E. Mullis, et al.. (2015). A 2‐year multicentre, open‐label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study. Clinical Endocrinology. 84(3). 353–360. 4 indexed citations
5.
Petkovic, Vibor, et al.. (2014). Alteration of ZnT5-Mediated Zinc Import into the Early Secretory Pathway Affects the Secretion of Growth Hormone from Rat Pituitary Cells. Hormone Research in Paediatrics. 82(4). 245–251. 5 indexed citations
6.
7.
Petkovic, Vibor, et al.. (2012). Isolated Growth Hormone Deficiency Type 2: From Gene to Therapy. Endocrine development. 23. 109–120. 5 indexed citations
8.
Mullis, Primus‐E.. (2011). Genetics of GHRH, GHRH-receptor, GH and GH-receptor: Its impact on pharmacogenetics. Best Practice & Research Clinical Endocrinology & Metabolism. 25(1). 25–41. 20 indexed citations
9.
10.
Kamber, Matthias & Primus‐E. Mullis. (2010). The Worldwide Fight Against Doping: From the Beginning to the World Anti-Doping Agency. Endocrinology and Metabolism Clinics of North America. 39(1). 1–9. 14 indexed citations
11.
Flück, C.E., et al.. (2010). Metabolic control of type 1 diabetic patients followed at the University Children’s Hospital in Bern: Have we reached the goal?. Swiss Medical Weekly. 140(2728). w13057–w13057. 8 indexed citations
12.
Pozo, E. del, J. Zapf, Andrew MacKenzie, et al.. (2009). Experimental arthritis: Effect on growth parameters and total skeletal calcium. Growth Hormone & IGF Research. 19(5). 442–446. 2 indexed citations
13.
Mullis, Primus‐E., et al.. (2008). Regulation of fetal growth: Consequences and impact of being born small. Best Practice & Research Clinical Endocrinology & Metabolism. 22(1). 173–190. 31 indexed citations
14.
Bianchetti, M G, et al.. (2003). Which factors account for renal stone formation in cystic fibrosis?. Clinical Nephrology. 59(3). 160–163. 10 indexed citations
15.
Joss, E, Rolf P. Zurbrügg, O Tönz, & Primus‐E. Mullis. (2000). Effect of Growth Hormone and Oxandrolone Treatment on Glucose Metabolism in Turner Syndrome. Hormone Research in Paediatrics. 53(1). 1–8. 3 indexed citations
16.
Mullis, Primus‐E.. (2000). Transcription Factors in Pituitary Gland Development and Their Clinical Impact on Phenotype. Hormone Research in Paediatrics. 54(3). 107–119. 20 indexed citations
17.
Truttmann, Anita C., et al.. (1998). Childhood Insulin-Dependent Diabetes mellitus: Initial Presentation and Management in the Nineties. PubMed. 24(5). 326–329. 2 indexed citations
18.
Janner, Marco, et al.. (1994). Persistent microalbuminuria in adolescents with Type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. European Journal of Pediatrics. 153(6). 403–408. 31 indexed citations
19.
Bianchetti, Mario G., et al.. (1993). High Proximal Excretion of Sodium during Activation of β<sub>2</sub>-Adrenoreceptors in Humans. ˜The œNephron journals/Nephron journals. 64(4). 576–579. 2 indexed citations
20.
Mullis, Primus‐E., et al.. (1988). Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical evidence of nephropathy. European Journal of Pediatrics. 147(4). 385–388. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bogda Skowrońska Breakdown of academic impact, for papers by M. C. Carranza Breakdown of academic impact, for papers by Christine Cavalcanti-Proença Breakdown of academic impact, for papers by Teresa Frazer Breakdown of academic impact, for papers by Yiyang Zhan Breakdown of academic impact, for papers by Stefania Moia Breakdown of academic impact, for papers by Joseph M. Tibaldi Breakdown of academic impact, for papers by Ross M. Fraser Breakdown of academic impact, for papers by Andressa G. Amaral Breakdown of academic impact, for papers by Witold Bauer
Rankless by CCL
2026